Form 4 CONMED CORP For: Oct 25 Filed by: KENNEDY JOHN JED

CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: SEC EDGAR

Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- Carpal Tunnel Release Systems Market to Exceed US$ 1,036.4 Million by 2035, Driven by Minimally Invasive Advances and Aging Population – Latest Report by Transparency Market Research Inc. [Yahoo! Finance]Yahoo! Finance
- CONMED Corporation Adds Mark Kaye to its Board of DirectorsBusiness Wire
- CONMED Corporation Announces Quarterly Cash DividendBusiness Wire
- CONMED Co. (NYSE: CNMD) had its price target raised by analysts at Stifel Nicolaus from $72.00 to $75.00. They now have a "buy" rating on the stock.MarketBeat
- Q4 2024 Conmed Corp Earnings Call [Yahoo! Finance]Yahoo! Finance
CNMD
Earnings
- 2/5/25 - Beat
CNMD
Sec Filings
- 3/11/25 - Form 4
- 3/5/25 - Form 4
- 3/5/25 - Form 4
- CNMD's page on the SEC website